 |
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
 |
||||||||||||||||
|
||||||||||||||||
|
|
|
|
Stock data
| Last Trade | 37.94 | Trade Time | 5/23/2013 4:00:00 PM |
| Change |  1.62
|
Volume (thou) | 1294.538 |
| %Change | 4.46% | Last Trade Size | |
| Open | 35.57 | Bid | 37.51 |
| Today's High | 38.33 | Ask | 38.28 |
| Today's Low | 35.14 | Size Bid/Ask | 1 x5 |
Fundamental Data |
|||
| Market Cap (mil) | 1210665.4 | 52 Week High | 45.00 |
| Shrs Outstanding (thou) | 31910000 | 52 Week Low | 3.30 |
| EPS | -5.68 | PE Ratio | .00 |
| Volatility | Yield | .00 | |
| Dividend Freq. | 0 | Ex-Dividend Date | 7/12/2012 |
| Dividend Amount | 0.16667 | Exchange | NASDAQ GM |
| Delayed quotes powered by S&P comstock. All stock quotes are delayed by 20 minutes and are believed to be accurate but are not warranted or guaranteed by MENAFN.com | |||
Related News
 |
May 10, 2013 | Sarepta Therapeutics to Present Company Overview at Upcoming Conferences, Marketwire |
|
May 09, 2013 | Sarepta Therapeutics Announces First Quarter 2013 Financial Results and Recent Corporate Developments, Marketwire |
|
May 07, 2013 | Sarepta Therapeutics Initiates Dosing in Phase I Multiple Ascending Dose Study of Drug for Treatment of Marburg Virus, Marketwire |
|
Apr 26, 2013 | Sarepta Therapeutics to Announce First Quarter 2013 Financial Results and Corporate Update on May 9, 2013, Marketwire |
 more... |
||
